Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Canada
  4. Toronto Stock Exchange
  5. Theratechnologies Inc.
  6. Nieuws
  7. Andere talen
    TH   CA88338H1001

THERATECHNOLOGIES INC.

(TH)
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op THERATECHNOLOGIES INC.
2021THERATECHNOLOGIES INC. COMMON SHARES : - Form 6-K
2021Theratechnologies Seeks FDA Nod for Trogarzo Intravenous Push in HIV Patients; Shares R..
2021Theratechnologies Submits Supplemental Biologics License Application to the FDA For Tr..
2021Theratechnologies Submits Supplemental Biologics License Application to FDA Advancing D..
2021Theratechnologies dépose une demande supplémentaire de licence de produit biologique au..
2021Theratechnologies Inc. Submits Supplemental Biologics License Application to FDA Advanc..
2021Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Scien..
2021Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Scien..
2021Theratechnologies lauréate du prix innovation de l'ADRIQ 2021 dans la catégorie ę scien..
2021THERATECHNOLOGIES : Announces Renewal of Shelf Prospectus and Registration Statement; At-T..
2021THERATECHNOLOGIES : Decision Document (Preliminary)
2021Theratechnologies Reports Plan to Offer US$150 Million in Securities; Down 2.1%
2021THERATECHNOLOGIES BRIEF : Announces Renewal of Shelf Prospectus and Registration Statement..
2021Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-..
2021Theratechnologies fera une présentation à la 30ème conférence annuelle de Crédit Suisse..
2021Theratechnologies fera une présentation à la 30ème conférence annuelle de Crédit Suisse..
2021Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on ..
2021Theratechnologies On Reimbursement Agreement In Italy for Trogarzo, for Eligible Patien..
2021THERATECHNOLOGIES BRIEF : Earlier Tuesday Reimbursement Agreement In Italy for Trogarzo, f..
2021THERATECHNOLOGIES : Secures Reimbursement Deal in Italy for HIV-1 Drug
2021Theratechnologies annonce un accord de remboursement en Italie pour Trogarzoģ pour les ..
2021THERATECHNOLOGIES : annonce un accord de remboursement en Italie pour Trogarzoģ pour les p..
2021THERATECHNOLOGIES : Announces Reimbursement Agreement in Italy for Trogarzoģ for Eligible ..
2021Theratechnologies Announces Reimbursement Agreement in Italy for Trogarzo for Eligible ..
2021THERATECHNOLOGIES : Says Scientific Article Reports on Preclinical Models of Its Peptide-D..
2021THERATECHNOLOGIES : annonce une publication dans la revue Frontiers in Oncology soulignant..
2021THERATECHNOLOGIES : Announces Publication in Frontiers in Oncology Journal Highlighting SO..
2021Theratechnologies Announces Publication in Frontiers in Oncology Journal Highlighting S..
2021THERATECHNOLOGIES : Reports Financial Results for the Third Quarter of Fiscal 2021 and Pro..
2021THERATECHNOLOGIES : Fiscal Q3 Earnings Snapshot
2021THERATECHNOLOGIES : Interim Consolidated Financial Statements (in thousands of United Stat..
2021Theratechnologies Inc. Reports Earnings Results for the Third Quarter Ended August 31, ..
2021THERATECHNOLOGIES : Reports Q3 Consolidated Revenue US$17.85 Million; Provides Operational..
2021THERATECHNOLOGIES : Earnings Flash (TH.TO) THERATECHNOLOGIES Reports Q3 Revenue US$17.852 ..
2021THERATECHNOLOGIES : présente ses résultats financiers pour le troisième trimestre de l'exe..
2021THERATECHNOLOGIES : Reports Financial Results†for the Third Quarter of Fiscal 2021 and Pro..
2021THERATECHNOLOGIES : Therathechnologies présentera au H.C. Wainwright 5th Annual Nash Inves..
2021Therathechnologies présentera au H.C. Wainwright 5th Annual Nash Investor Conference
2021THERATECHNOLOGIES : annoncera ses résultats financiers du troisième†trimestre de l'exercic..
2021THERATECHNOLOGIES : to Announce Financial Results for Its Third Quarter Fiscal 2021
2021THERATECHNOLOGIES : Announces "Positive" Results for Trogarzo IV Push Administration Study
2021THERATECHNOLOGIES BRIEF : Announces "Positive" Results for Trogarzo IV Push Administration..
2021Theratechnologies annonce que l'étude sur l'administration de Trogarzo(MD) par injectio..
2021Theratechnologies Inc. Announces Positive Results for Trogarzoģ IV Push Administration ..
2021Theratechnologies participe à la conférence mondiale sur les soins de santé Cantor Fitz..
2021THERATECHNOLOGIES : to Present at the Cantor Fitzgerald Global Healthcare Conference on Se..
2021THERATECHNOLOGIES : fera une présentation à la 23e conférence annuelle mondiale de H.C. Wa..
2021THERATECHNOLOGIES : to Present at the H.C. Wainwright 23rd Annual Global Investment Confer..
2021THERATECHNOLOGIES : to Host Key Opinion Leader Event to Discuss Tesamorelin for the Treatm..
2021THERATECHNOLOGIES : organisera un événement avec des chefs d'opinion clés pour parler de l..
2021SNC LAVALIN : Ontario Affirms Gatekeeping Function Of Robust Leave Test For Securities Cla..
2021THERATECHNOLOGIES BRIEF : Announces Publication of TH1902 Preclinical Data in Peer-Reviewe..
2021Theratechnologies annonce la publication de données précliniques sur le TH1902 dans Can..
2021Theratechnologies, Inc. Announces Publication of TH1902 Preclinical Data in Peer-Review..
2021Theratechnologies to Present at the Canaccord Genuity 41st Annual Growth Conference
2021THERATECHNOLOGIES : Establishes New At-The-Market Facility (Form 6-K)
2021THERATECHNOLOGIES : Dual Listed Theratechnologies Establishes New At-The-Market Facility
2021THERATECHNOLOGIES : Controlled Equity OfferingSM Sales Agreement (Form 6-K)
2021THERATECHNOLOGIES : Establishes New At-The-Market Facility
2021THERATECHNOLOGIES : MATERIAL CHANGE REPORT FORM 51-102F3 (Form 6-K)
2021THERATECHNOLOGIES : Establishes New At-The-Market Facility
2021THERATECHNOLOGIES : Établit Un Programme de Placements d'Actions au cours du marché
2021THERATECHNOLOGIES : Says Phase 3 NASH Clinical Trial to be Delayed, Higher Costs Expected,..
2021THERATECHNOLOGIES : Fiscal Q2 Earnings Snapshot
2021THERATECHNOLOGIES : Narrows Loss in Q2, Revenue Rises
2021Theratechnologies Inc. Reports Earnings Results for the Second Quarter Ended May 31, 20..
2021THERATECHNOLOGIES : Interim Consolidated Financial Statements (in thousands of United Stat..
2021THERATECHNOLOGIES : Material Event (Form 6-K)
2021Theratechnologies Inc. Reports Revenue Results for the Second Quarter Ended May 31, 202..
2021THERATECHNOLOGIES : Earnings Flash (TH.TO) THERATECHNOLOGIES Reports Q2 Revenue US$17.787 ..
2021Theratechnologies présente ses résultats financiers pour le deuxième trimestre de l'exe..
2021THERATECHNOLOGIES : Reports Financial Results for the Second Quarter of Fiscal 2021 and Pr..
2021Theratechnologies Inc. Reports Provides Update on Its Planned Phase 3 Clinical Trial in..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021CORRECTION : Theratechnologies annoncera ses résultats du deuxième trimestre de l'exercice..
1  2  3  4  5  6  7Volgende
Volgende evenement op THERATECHNOLOGIES INC.
24/02/22